Novel expression of cyclin-dependent kinase inhibitors in human B-cell precursors

Experimental Hematology

Volumn 29, Issue 4, 2001, Pages 490-498

  Fink, Jason R ^a   LeBien, Tucker W ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b Mayo Mail Code 609   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D2; CYCLIN D3; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLINE; PROTEIN INK4; PROTEIN INK4A; PROTEIN INK4D; PROTEIN P16; PROTEIN P19; PROTEIN P57; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL DIVISION; CELL MATURATION; COMPARATIVE STUDY; CONTROLLED STUDY; EUKARYOTIC CELL; FETUS; FETUS CELL; FLUORESCENCE ACTIVATED CELL SORTER; GENE DELETION; GENE EXPRESSION; GENETIC CODE; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; WESTERN BLOTTING;

ANTIGENS, CD19; ANTIGENS, CD34; B-LYMPHOCYTES; BONE MARROW CELLS; CARRIER PROTEINS; CELL CYCLE PROTEINS; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE 6; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P19; CYCLIN-DEPENDENT KINASES; CYCLINS; EMBRYO; ENZYME INHIBITORS; FUNGAL PROTEINS; GENE EXPRESSION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; MICROTUBULE-ASSOCIATED PROTEINS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SACCHAROMYCES CEREVISIAE PROTEINS; TUMOR CELLS, CULTURED;

EUKARYOTA; MURINAE;

EID: 0035071989     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(01)00619-1     Document Type: Article

References (37)

1. A long twentieth century of the cell cycle and beyond
2. Inhibitors of mammalian G1 cyclin-dependent kinases
3. CDK inhibitors; positive and negative regulators of G1-phase progression
4. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest
5. The ARF/p53 pathway
6. Cancer cell cycles
7. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer
8. The hallmarks of cancer
9. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells
10. Fates of human B-cell precursors
11. Clonal selection and learning in the antibody system
12. Establishment of a leukemic cell model for studying human pre-B to B cell differentiation
13. Development of a model for evaluating the interaction between human pre-B acute lymphoblastic leukemic cells and the bone marrow stromal cell microenvironment
14. Comparative detection and quantitation of human CDK inhibitor mRNA expression of p15INK4B, p16INK4A, p16β, p18INK4C, p19INK4D, p21WAF1, p27KIP1, and p57KIP2 by RT-PCR using a polycompetitive internal standard
15. Differential myeloma cell responsiveness to interferon-α correlates with differential induction of p19 (INK4d) and cyclin D2 expression
16. IgH gene segment transcription and rearrangement prior to surface expression of the pan B cell marker CD19 in normal human bone marrow
17. 1 cyclin that binds Cdk2 and is aberrantly expressed in human cancers
18. Cyclin E2; a novel CDK2 partner in the late G1 and S phases of the mammalian cell cycle
19. Immunohistochemical survey of p16INK4A expression in normal human adult and infant tissues
20. Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging
21. Involvement of the Ink4 proteins p16 and p15 in T-lymphocyte senescence
22. ARF in hematological malignancies
23. Cell cycle regulatory gene abnormalities are important determinants of leukemogenesis and disease biology in adult acute lymphoblastic leukemia
24. Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumor suppressor p16INK4a
25. Distinct versus redundant properties among members of the INK4 family of cyclin-dependent kinase inhibitors
26. Lack of mutation in the cyclin-dependent kinase inhibitor, p19INK4d in tumor-derived cell lines and primary tumors
27. INK4d-deficient mice are fertile despite testicular atrophy
28. KIP2 is degraded through the proteasome in osteoblasts stimulated to proliferation by transforming growth factor β1
29. KIP2 in trophoblast giant cells defines a G2-like gap phase of the endocycle
30. Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development
31. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
32. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27 (Kip1)-deficient mice
33. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27 (Kip1)
34. KIP2
35. Modulation of the p27kip1 cyclin-dependent kinase inhibitor expression during IL-4-mediated human B cell activation
36. A pivotal role of cyclin D3 and cyclin-dependent kinase inhibitor p27 in the regulation of IL-2-, IL-4-, or IL-10-mediated human B cell proliferation
37. Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes